Related Subjects:
|Dilated Cardiomyopathy
|Hypertrophic cardiomyopathy (HCM - HOCM)
|Peripartum cardiomyopathy
|Restrictive Cardiomyopathy
|Takotsubo Cardiomyopathy
๐ Hypertrophic Cardiomyopathy (HCM) may present in adolescence with cardiac arrest or sudden death.
Genetic in origin, but even when no mutation is found, first-degree relatives require ECG + echo screening.
๐ About
- Defined as LV hypertrophy (LVH) with wall thickness >15 mm.
- Causes diastolic dysfunction (stiff ventricle, impaired filling).
- Risk of SVT and VT โ prevalence ~1 in 500 adults.
- Can mimic aortic stenosis clinically.
๐งฌ Aetiology & Genetics
- Mostly autosomal dominant, but can be sporadic or de novo.
- Mutations in sarcomere proteins:
- ๐ MYH7 (beta-myosin heavy chain)
- ๐ต MYBPC3 (myosin-binding protein C)
- Others: troponin T/I, ฮฑ-tropomyosin, titin, actin.
- Pathology: myocyte disarray + fibrosis.
Septal hypertrophy โ LV outflow obstruction (LVOTO).
Apical HCM more common in Japan ๐ฏ๐ต.
๐งโโ๏ธ Associations
- Mitral valve prolapse
- Phaeochromocytoma
- Noonanโs syndrome
- WPW syndrome
๐ฉบ Clinical Presentation
- Often asymptomatic (picked up on screening).
- Symptoms:
- ๐ฅ Exertional chest pain (angina)
- โค๏ธ Palpitations (AF, VT)
- ๐ฌ๏ธ Dyspnoea (diastolic dysfunction)
- ๐ต Syncope/pre-syncope (exercise-related)
- โก Sudden death (esp. young athletes)
โ ๏ธ Risk Factors for Sudden Cardiac Death (SCD)
| Risk Factor | Why Important |
| ๐จโ๐ฉโ๐ฆ Family history of SCD | Particularly <50 yrs in 1st-degree relative |
| ๐ต Unexplained syncope | Recent (last 6 months) = high risk |
| ๐ NSVT on Holter | โฅ3 beats, >120 bpm, <30 sec |
| ๐ช Severe LVH | Wall thickness โฅ30 mm |
| ๐ฉบ Abnormal BP response | Failure to rise โฅ20 mmHg on exercise |
| ๐งฒ Myocardial fibrosis | LGE on MRI = arrhythmogenic substrate |
| ๐ง LVOT obstruction | Gradient โฅ30 mmHg at rest |
๐ Examination
- Irregular pulse (if AF).
- JVP: prominent 'a' wave.
- Jerky/bisferiens pulse, triple apical impulse.
- ๐ง Murmurs:
- Pan-systolic (mitral regurg)
- Late systolic (LVOTO) โ louder on standing/Valsalva, softer on squatting.
๐งช Investigations
- ECG: LVH, deep T inversion, pseudo-infarct Q waves, AF.
- Echo: Asymmetrical septal hypertrophy, SAM of MV, diastolic dysfunction.
- Cardiac MRI: Detailed anatomy + fibrosis (LGE).
- Coronary angiography: Exclude CAD if angina symptoms.
๐ Management
- Pharmacological:
- ๐ฅ Beta-blockers = first-line
- Verapamil if BB contraindicated
- Disopyramide (negative inotrope) for LVOTO
- โ Avoid vasodilators, diuretics, high-dose nitrates (worsen obstruction)
- Procedures:
- ๐ช Septal myectomy (definitive for LVOTO)
- ๐ท Alcohol septal ablation (less invasive)
- โก ICD for high SCD risk
- Lifestyle:
- Avoid competitive sports ๐โโ๏ธ
- Regular follow-up echo/MRI
- Family screening & genetic counselling ๐จโ๐ฉโ๐ง
๐ถ Family Screening
- If mutation identified โ genetic test relatives.
- If not โ ECG + echo:
- Children: every 3 yrs until puberty, then annually until 20.
- If normal in early adulthood โ low risk of later development.
๐ฆ Exam Red Flags: Syncope + LVH โฅ30 mm + family history of SCD โ ICD indicated.
๐ References